首页> 外文期刊>Biotechnology Progress >Dynamic Mechanistic Modeling of the Multienzymatic One-Pot Reduction of Dehydrocholic Acid to 12-Keto Ursodeoxycholic Acid with Competing Substrates and Cofactors
【24h】

Dynamic Mechanistic Modeling of the Multienzymatic One-Pot Reduction of Dehydrocholic Acid to 12-Keto Ursodeoxycholic Acid with Competing Substrates and Cofactors

机译:具有竞争性底物和辅助因子的多酶一锅法将脱氢胆酸还原为12-酮基去氧胆酸的动力学机理的动力学模型

获取原文
获取原文并翻译 | 示例
           

摘要

Ursodeoxycholic acid (UDCA) is a bile acid which is used as pharmaceutical for the treatment of several diseases, such as cholesterol gallstones, primary sclerosing cholangitis or primary biliary cirrhosis. A potential chemoenzymatic synthesis route of UDCA comprises the two-step reduction of dehydrocholic acid to 12-keto-ursodeoxycholic acid (12-keto-UDCA), which can be conducted in a multienzymatic one-pot process using 3-hydroxysteroid dehydrogenase (3-HSDH), 7-hydroxysteroid dehydrogenase (7-HSDH), and glucose dehydrogenase (GDH) with glucose as cosubstrate for the regeneration of cofactor. Here, we present a dynamic mechanistic model of this one-pot reduction which involves three enzymes, four different bile acids, and two different cofactors, each with different oxidation states. In addition, every enzyme faces two competing substrates, whereas each bile acid and cofactor is formed or converted by two different enzymes. First, the kinetic mechanisms of both HSDH were identified to follow an ordered bi-bi mechanism with EBQ-type uncompetitive substrate inhibition. Rate equations were then derived for this mechanism and for mechanisms describing competing substrates. After the estimation of the model parameters of each enzyme independently by progress curve analyses, the full process model of a simple batch-process was established by coupling rate equations and mass balances. Validation experiments of the one-pot multienzymatic batch process revealed high prediction accuracy of the process model and a model analysis offered important insight to the identification of optimum reaction conditions. (c) 2015 American Institute of Chemical Engineers Biotechnol. Prog., 31:375-386, 2015
机译:熊去氧胆酸(UDCA)是一种胆汁酸,可用于治疗多种疾病,例如胆固醇胆结石,原发性硬化性胆管炎或原发性胆汁性肝硬化。 UDCA的潜在化学酶法合成路线包括将脱氢胆酸两步还原为12-酮-熊去氧胆酸(12-keto-UDCA),可使用3-羟基类固醇脱氢酶在多酶一锅法中进行(3- HSDH),7-羟基类固醇脱氢酶(7-HSDH)和葡萄糖脱氢酶(GDH),其中葡萄糖作为辅因子再生的共底物。在这里,我们提出了这种一锅还原的动力学机制模型,该模型涉及三种酶,四种不同的胆汁酸和两种不同的辅因子,每种辅因子具有不同的氧化态。另外,每种酶面对两种竞争的底物,而每种胆汁酸和辅因子是由两种不同的酶形成或转化的。首先,确定了两个HSDH的动力学机制都遵循有序的bi-bi机制,并具有EBQ型非竞争性底物抑制作用。然后,针对该机理和描述竞争性底物的机理得出速率方程。通过进度曲线分析独立估算每种酶的模型参数后,通过耦合速率方程和质量平衡建立了简单批处理的全过程模型。一锅多酶间歇过程的验证实验表明,该过程模型具有较高的预测准确性,并且模型分析为确定最佳反应条件提供了重要的见识。 (c)2015美国化学工程师学会生物技术学会。 Prog。,31:375-386,2015

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号